Aspera Biomedicines Successfully Launches Second ADAR1p150 Protein Crystallization Experiment to the International Space Station Aboard SpaceX CRS-34 Aspera Biomedicines Inc., a biotechnology company focused on developing first-in-class therapies targeting cancer stem cells, has successfully launched its second ADAR1p150 protein crystallization…
Savara Presents New Exercise Capacity Data from IMPALA-2 Phase 3 Trial of Molgramostim in aPAP at ATS 2026 International Conference Savara a clinical-stage biopharmaceutical company focused on developing therapies for rare respiratory diseases, announced new clinical findings from its IMPALA-2…
KORU Medical Systems Presents Real-World Evidence on FreedomEDGE® Syringe Infusion System at 51st Oncology Nursing Society Congress KORU Medical Systems,a leading medical technology company specializing in innovative and patient-centered large-volume subcutaneous infusion solutions, announced that it recently presented new real-world…
Vir Biotechnology to Showcase Full 96-Week Phase 2 SOLSTICE Hepatitis Delta Trial Results at European Association for the Study of the Liver Congress 2026 Vir Biotechnology announced that new clinical data from its Phase 2 SOLSTICE trial evaluating the investigational…
Stryker Enrolls First Patient in Coronary IVL Study Stryker has reached a major milestone in the advancement of cardiovascular treatment technology following the enrollment of the first patient in the POWER CAD I clinical study, a first-in-human trial evaluating the…
Kin Health Lands $9M Funding to Improve Patient Access to Personal Healthcare Data Kin Health, a healthcare technology startup founded by practicing physicians, has announced a $9 million seed funding round aimed at transforming how patients understand and manage their…
CareTrust REIT, Inc. Prices Enlarged Public Common Stock Offering CareTrust REIT, Inc. has announced the pricing of an enlarged underwritten public offering of its common stock, a move expected to generate approximately $509.4 million in gross proceeds through a forward…
Why access and outcomes must evolve together in mental health care Mental health care in the United States is at a critical moment. Nearly one in four adults experiences a mental health condition each year, yet many still struggle to access…
Geneva participation highlights Malaysia’s public-private partnership model for early detection and occupational lung health IHH Healthcare Malaysia joined lung health discussions held alongside the 79th World Health Assembly in Geneva, bringing Malaysia’s public-private partnership model to a global platform focused…
Microbot Medical to Hold Analysts and Investors Conference Call to Review Recent Progress; Executive Team will be Joined by Current Users of the LIBERTY Endovascular Robotic System, Dr. Charles Briggs and Dr. Zachary Bercu Microbot Medical Inc., developer and distributor…
NEJM Publishes Shionogi Phase 3 SCORPIO-PEP Study Showing Ensitrelvir Significantly Reduces COVID-19 Risk After Exposure Shionogi & Co., Ltd. announced that results from its global Phase 3 clinical trial, SCORPIO-PEP, evaluating the investigational oral antiviral ensitrelvir for post-exposure prophylaxis (PEP)…
Cord for Life® Completes Historic Phase 1 Clinical Trial Exploring Cord Blood Stem Cell Therapy for Lower Back Pain Cord for Life®has announced the successful completion of Phase 1 enrollment and dosing in a groundbreaking clinical trial investigating the use…